Skip to main content

Schneider Eugene

In the past year, 4 open-market sale filings worth $3.74M and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$3.74M
4 filings
Net
−$3.74M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Schneider Eugene as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 30, 2026 (view filing)Jun 264 daysSchneider EugeneEVP, Chf Clinical Develop OfcrSSale−26.0K$81.05−$2.11M−25.2%77.1K after10b5-1
Mar 23, 2026 (view filing)Mar 194 daysSchneider EugeneEVP, Chf Clinical Develop OfcrSSale−5.81K$70.97−$412.5K−8.3%63.9K after10b5-1
Feb 2, 2026 (view filing)Jan 303 daysSchneider EugeneEVP, Chf Clinical Develop OfcrSSale−6.18K$83.45−$515.6K−8.1%69.7K after
Jan 20, 2026 (view filing)Jan 164 daysSchneider EugeneEVP, Chf Clinical Develop OfcrSSale−9.30K$75.59−$703.1K−12.7%63.9K after
Sep 4, 2025 (view filing)Sep 31 daySchneider EugeneEVP, Chf Clinical Develop OfcrSSale−19.7K$60.81−$1.20M−27.6%51.5K after2 lots10b5-1
Aug 5, 2025 (view filing)Aug 41 daySchneider EugeneEVP, Chf Clinical Develop OfcrSSale−9.55K$42.80−$408.7K−15.6%51.5K after10b5-1
Feb 3, 2025 (view filing)Jan 313 daysSchneider EugeneEVP, Chf Clinical Develop OfcrSSale−1.48K$32.20−$47.8K−2.4%61.1K after
Jan 17, 2025 (view filing)Jan 161 daySchneider EugeneEVP, Chf Clinical Develop OfcrSSale−6.52K$32.79−$213.9K−10.0%58.5K after
Sep 4, 2024 (view filing)Feb 2215 daysSchneider EugeneEVP, Chf Clinical Develop OfcrSSale−2.11K$49.59−$104.4K−4.2%47.7K afterAmended
Jan 18, 2024 (view filing)Jan 171 daySchneider EugeneEVP, Chf Clinical Develop OfcrSSale−5.48K$50.42−$276.4K−10.3%47.9K after
Jan 17, 2024 (view filing)Jan 125 daysSchneider EugeneEVP, Chf Clinical Develop OfcrSSale−8.00K$53.50−$428.0K−17.3%38.2K after10b5-1
Dec 28, 2023 (view filing)Dec 262 daysSchneider EugeneEVP, Chf Clinical Develop OfcrSSale−25.0K$51.46−$1.29M−40.9%36.1K after10b5-1
Feb 7, 2023 (view filing)Feb 61 daySchneider EugeneEVP, Chf Clinical Develop OfcrSSale−1.41K$40.67−$57.5K−5.4%24.9K after
Jan 19, 2023 (view filing)Jan 181 daySchneider EugeneEVP, Chf Clinical Develop OfcrSSale−4.75K$39.57−$188.0K−17.5%22.3K after